15.500
−0,64%
2026-10-19
Fundamental Analysis
41 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +6.9% | +4.2% | 2 / 3 | +5.5% | +1.90 pp | +0.06 pp | +2.5% | 0.06 | 53.80 | 71,8 | +5,5% | 3,4 | +6,9% | 53.80 | 63.67 | −15,5% |
| Pts | 0 | 0 | 8 | 0 | 8 | 8 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 15.500 (close price on 2026-10-19)EPS (TTM): 288,1
Financial charts
1.Revenue & growth
VND bn71,8Q2/26
1.Revenue & growth
VND bn71,8Q2/26
2.Profit & growth
VND bn3,18Q2/26
3.Profit mix (Penman)
VND bn16,2Q2/26
4.Margins & cost structure
%26.0%Q2/26
5.Returns & cash cycle
% · days3.2%Q2/26
6.Earnings quality & cash
VND bn36,1Q2/26
7.Asset structure
VND bn544Q2/26
8.Funding & debt health
VND bn · times544Q2/26
9.Revenue backlog
VND bn0,83Q2/26
10.Valuation
times · %54,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %80Q2/26
Adjusted EPS growth, latest quarter
1.5%
Average adjusted EPS growth, 3 quarters
2.4%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26